Google Ventures is betting more and more on life sciences startups each year, and the well-funded financier tells The Wall Street Journal that’s not going to change in the new year. In 2014, Google poured more than one-third of its $425 million venture fund into healthcare and life sciences companies, according to lead investor Bill Maris, up from just 9% in 2013. And, rolling into next year, Maris expects Google Ventures to maintain roughly the same dollar value and strategic focus.